|
|
|
|
|
Phototherapy for early-stage mycosis fungoides in thais |
2562 |
# |
|
|
|
|
|
Photosensitivity disorders in children Part II |
2555 |
# |
|
|
|
|
|
Photosensitivity disorders in children Part I |
2555 |
# |
|
|
|
|
|
Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives |
2563 |
# |
|
|
|
|
|
Photoprotective habits in children with systemic lupus erythematosus |
2563 |
# |
|
|
|
|
|
Photoprotection by window glass, automobile glass, and sunglasses |
2549 |
# |
|
|
|
|
|
Photoprotection by dietary phenolics against melanogenesis induced by UVA through Nrf2-dependent antioxidant responses |
2559 |
# |
|
|
|
|
|
Photopolymerization of hydrogels for cartilage tissue engineering |
2559 |
# |
|
|
|
|
|
Photopneumatic therapy for the treatment of acne. |
2552 |
# |
|
|
|
|
|
Photopatch testing in a tropical country, Thailand: 20 years' experience |
2564 |
# |
|
|
|
|
|
Phospholipase C of Cryptococcus neoformans Regulates Homeostasis and Virulence by Providing Inositol Trisphosphate as a Substrate for Arg1 Kinase |
2556 |
# |
|
|
|
|
|
Phosphate inhibits calcium oxalate crystal growth and crystallization through reducing free calcium ions: a morphological analysis and calcium consumption assay |
2555 |
# |
|
|
|
|
|
Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG. |
2563 |
# |
|
|
|
|
|
Phenotypic Features of Carbohydrate Sulfotransferase 3 (CHST3) Deficiency in 24 Patients: Congenital Dislocations and Vertebral Changes as Principal Diagnostic Features |
2553 |
# |
|
|
|
|
|
Phenotypic Characterization of Corneal Epithelium in Patients With Long-term Follow-up Who Underwent Autologous Cultivated Oral Mucosal Epithelial Transplantation |
2563 |
# |
|
|
|
|
|
Phenotypic characterization of circulating CD4/CD8 T-lymphocytes in β-thalassemia patients. |
2557 |
# |
|
|
|
|
|
Phenotypic Characterization of a Large European Family with Brugada Syndrome Displaying a Sudden Unexpected Death Syndrome Mutation in SCN5A: Female Predominance in the Signs and Symptoms of the Disease |
2552 |
# |
|
|
|
|
|
Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels. |
2559 |
# |
|
|
|
|
|
Phenotypic and mutation spectrums of Thai patients with isovaleric acidemia |
2554 |
# |
|
|
|
|
|
Phenotypic and functional assessment of the role of tregs in SIV infected disease susceptible and disease resistant rhesus macaques and mangabeys |
2550 |
# |
|
|
|
|
|
PHENOTYPE-GENOTYPE CHARACTERISTICS AND BASELINE NATURAL HISTORY OF HERITABLE NEUROPATHIES CAUSED BY MUTATIONS IN THE MYELIN PROTEIN ZERO GENE |
2558 |
# |
|
|
|
|
|
pHCR: a parallel haplotype configuration reduction algorithm for haplotype interaction analysis. |
2552 |
# |
|
|
|
|
|
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix |
2554 |
# |
|
|
|
|
|
Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup |
2560 |
# |
|
|
|
|
|
Phase III KEYNOTE-048 study of first-line (1L) pembrolizumab (P) for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Asia vs non-Asia subgroup (subgrp) analysis |
2562 |
# |
|
|
|
|
|
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer |
2544 |
# |
|
|
|
|
|
Phase II study of the combination of gemcitabine plus carboplatin as neoadjuvant treatment in locally advanced breast cancer |
2553 |
# |
|
|
|
|
|
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma |
2555 |
# |
|
|
|
|
|
Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma |
2544 |
# |
|
|
|
|
|
Phase II study of carboplatin and paclitaxel in metastatic and/or recurrent NPC: A multicenter study |
2547 |
# |